Penn State Milton S Hershey Medical Center Allergy and Immunology

Residency · Hershey, PA

Sponsored by Penn State Milton S Hershey Medical Center · Director Gisoo Ghaffari

Works by its people: 606
Authors: 36
First-author works: 181
Citations: 22,126

20112026

Topics

Coagulation, Bradykinin, Polyphosphates, and Angioedema 184
Asthma and respiratory diseases 71
Allergic Rhinitis and Sensitization 46
Drug-Induced Adverse Reactions 22
Eosinophilic Esophagitis 20
Food Allergy and Anaphylaxis Research 15
Immunodeficiency and Autoimmune Disorders 13
Urticaria and Related Conditions 10
Dermatology and Skin Diseases 9
Obstructive Sleep Apnea Research 8
Protease and Inhibitor Mechanisms 8
Contact Dermatitis and Allergies 5

Most cited

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
Allergy · 2022 · 435 citations · Timothy Craig
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.
Allergy · 2026 · 36 citations · Timothy Craig
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.
The Journal of allergy and clinical immunology · 2024 · 89 citations · Timothy Craig
IL-1β and the Intestinal Epithelial Tight Junction Barrier.
Frontiers in immunology · 2021 · 357 citations · Lauren Kaminsky
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema.
The journal of allergy and clinical immunology. In practice · 2021 · 305 citations · Timothy Craig
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2023 · 110 citations · Timothy Craig
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.
Blood advances · 2023 · 131 citations · Liyan Mazahreh
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
The Journal of allergy and clinical immunology · 2021 · 132 citations · Timothy Craig

Topics

Coagulation, Bradykinin, Polyphosphates, and Angioedema 184

Asthma and respiratory diseases 71

Allergic Rhinitis and Sensitization 46

Drug-Induced Adverse Reactions 22

Eosinophilic Esophagitis 20

Food Allergy and Anaphylaxis Research 15

Immunodeficiency and Autoimmune Disorders 13

Urticaria and Related Conditions 10

Dermatology and Skin Diseases 9

Obstructive Sleep Apnea Research 8

Protease and Inhibitor Mechanisms 8

Contact Dermatitis and Allergies 5

Most cited

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.

Allergy · 2022 · 435 citations · Timothy Craig

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy · 2026 · 36 citations · Timothy Craig

Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.

The Journal of allergy and clinical immunology · 2024 · 89 citations · Timothy Craig

IL-1β and the Intestinal Epithelial Tight Junction Barrier.

Frontiers in immunology · 2021 · 357 citations · Lauren Kaminsky

US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema.

The journal of allergy and clinical immunology. In practice · 2021 · 305 citations · Timothy Craig

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England) · 2023 · 110 citations · Timothy Craig

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.

Blood advances · 2023 · 131 citations · Liyan Mazahreh

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.

The Journal of allergy and clinical immunology · 2021 · 132 citations · Timothy Craig